CEA Paris- Saclay / MIRCen
The Molecular Imaging Research Centre (MIRCen) is a preclinical research centre created by CEA Paris-Saclay. Housed on nearly 8,500m2 of platforms, MIRCen brings together about a hundred researchers, engineers, technicians, doctoral and post-doctoral students from CEA Paris-Saclay, CNRS, and Inserm.
Focused on neuroimaging, it hosts high-level instrumental platforms and research teams with complementary expertise. The research carried out at this centre enables the development of technologies and methodologies for in vivo brain imaging, with the aim of improving early diagnosis and/or the evaluation of innovative therapies for neurodegenerative diseases.
Focused on neuroimaging, it hosts high-level instrumental platforms and research teams with complementary expertise. The research carried out at this centre enables the development of technologies and methodologies for in vivo brain imaging, with the aim of improving early diagnosis and/or the evaluation of innovative therapies for neurodegenerative diseases.
MIRCen is dedicated to the development of relevant animal models of human pathologies as well as to preclinical trials of gene, cell and drug therapy for the treatment of neurodegenerative diseases (mainly Alzheimer's, Parkinson's and Huntington's diseases).
In addition, MIRCen provides 14 platforms and technical facilities, including PET and MRI imaging, NMR spectroscopy, neurosurgery rooms, equipment dedicated to behavioural studies, as well as biochemistry and molecular biology laboratories. Most of these technical facilities and platforms operate at microbiological safety levels L2 and L3. This state-of-the-art equipment is used to evaluate neurodegeneration in animal models and to test innovative therapeutic strategies.
More details : François Jacob Institute of Biology - Plateforms & Services (cea.fr)
More details : François Jacob Institute of Biology - Plateforms & Services (cea.fr)
MIRCen thus has the essential platforms and expertise to undertake a translational research approach aimed at proposing, characterising and measuring in animals (rodents, non-human primates), the therapeutic efficacy of different approaches to cell, gene and/or drug therapies as well as new interventional surgical treatments.
Within the framework of an agreement between MIRCen and the Vision Institute (IDV), a preclinical ophthalmology platform dedicated to non-human primates has been set up and made available for collaborative studies.
Within the framework of an agreement between MIRCen and the Vision Institute (IDV), a preclinical ophthalmology platform dedicated to non-human primates has been set up and made available for collaborative studies.
➜ More about MIRCen : François Jacob Institute of Biology - MIRCen (cea.fr)